Responses
Letter
No sign of elevated cardiovascular risk in patients with seropositive rheumatoid arthritis who remain on stable antirheumatic therapy: results from the nationwide Norwegian Cardio-Rheuma Register
Compose a Response to This Article
Other responses
No responses have been published for this article.